230 related articles for article (PubMed ID: 11857071)
21. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
[TBL] [Abstract][Full Text] [Related]
22. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
[TBL] [Abstract][Full Text] [Related]
23. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
24. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus induced acute hepatitis in non-human primates after liver-directed gene therapy.
Lu H; Sullivan D; Gerber MA; Dash S
Chin Med J (Engl); 2002 May; 115(5):726-31. PubMed ID: 12133543
[TBL] [Abstract][Full Text] [Related]
26. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.
Iimuro Y; Nishio T; Morimoto T; Nitta T; Stefanovic B; Choi SK; Brenner DA; Yamaoka Y
Gastroenterology; 2003 Feb; 124(2):445-58. PubMed ID: 12557150
[TBL] [Abstract][Full Text] [Related]
27. Transplantation of urokinase-type plasminogen activator gene-modified bone marrow-derived liver stem cells reduces liver fibrosis in rats.
Sun C; Li DG; Chen YW; Chen YW; Wang BC; Sun QL; Lu HM
J Gene Med; 2008 Aug; 10(8):855-66. PubMed ID: 18481824
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial gene therapy renders increased survival in cirrhotic rats.
Gálvez-Gastélum FJ; Segura-Flores AA; Senties-Gomez MD; Muñoz-Valle JF; Armendáriz-Borunda JS
J Biomed Sci; 2010 May; 17(1):42. PubMed ID: 20509929
[TBL] [Abstract][Full Text] [Related]
29. [Effects of gene therapy with replication-defective adenovirus ericlosing Egr-1 promoter and Smad7 cDNA on irradiation-induced pulmonary fibrosis: experiment with mice].
Wang L; Feng Y; Fu XL; Cai XW
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2847-52. PubMed ID: 17200022
[TBL] [Abstract][Full Text] [Related]
30. Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.
Salgado S; Garcia J; Vera J; Siller F; Bueno M; Miranda A; Segura A; Grijalva G; Segura J; Orozco H; Hernandez-Pando R; Fafutis M; Aguilar LK; Aguilar-Cordova E; Armendariz-Borunda J
Mol Ther; 2000 Dec; 2(6):545-51. PubMed ID: 11124055
[TBL] [Abstract][Full Text] [Related]
31. Safe and efficient transgene expression in rat hepatocytes induced by adenoviral administration into the biliary tract.
Kuriyama S; Yoshiji H; Deguchi A; Nakai S; Ogawa M; Nonomura T; Kimura Y; Inoue H; Kinekawa F; Tsujimoto T; Masaki T; Kurokohchi K; Uchida N
Oncol Rep; 2005 May; 13(5):825-30. PubMed ID: 15809745
[TBL] [Abstract][Full Text] [Related]
32. AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers.
Sobrevals L; Enguita M; Rodriguez C; Gonzalez-Rojas J; Alzaguren P; Razquin N; Prieto J; Fortes P
Gene Ther; 2012 Apr; 19(4):411-7. PubMed ID: 21850051
[TBL] [Abstract][Full Text] [Related]
33. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
Bilbao R; Reay DP; Wu E; Zheng H; Biermann V; Kochanek S; Clemens PR
Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668
[TBL] [Abstract][Full Text] [Related]
34. Decorin gene transfer inhibited the expression of TGFbeta1 and ECM in rat mesangial cells.
Wu F; Yao H; Bader A; Dong F; Zhu F; Wu N; Wang B; Li H; Brockmeyer NH; Altmeyer P
Eur J Med Res; 2007 Aug; 12(8):360-8. PubMed ID: 17933714
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver.
Yu Q; Que LG; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G565-72. PubMed ID: 11842008
[TBL] [Abstract][Full Text] [Related]
36. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
37. Treating liver cirrhosis in dogs with hepatocyte growth factor gene therapy via the hepatic artery.
Horiguchi K; Hirano T; Ueki T; Hirakawa K; Fujimoto J
J Hepatobiliary Pancreat Surg; 2009; 16(2):171-7. PubMed ID: 19221688
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer and expression in rat anastomotic artery in vivo using adenoviral vector.
Huang Z; Guo J; Guo S
Chin Med J (Engl); 2001 Jun; 114(6):650-3. PubMed ID: 11780446
[TBL] [Abstract][Full Text] [Related]
39. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants.
Huard J; Lochmüller H; Acsadi G; Jani A; Massie B; Karpati G
Gene Ther; 1995 Mar; 2(2):107-15. PubMed ID: 7719927
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy progress and prospects: adenoviral vectors.
St George JA
Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
